Collectively, these results establish EZH2 as a downstream interacting partner of OLFML2A and suggest that its expression is positively regulated by OLFML2A in triple-negative breast cancer (TNBC) cells. This evidence concerns the gene EZH2 and triple-negative breast carcinoma.